Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pacira Pharm Inc
(NQ:
PCRX
)
22.33
+0.72 (+3.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,010,587
Open
21.73
Bid (Size)
21.90 (1)
Ask (Size)
22.80 (2)
Prev. Close
21.61
Today's Range
21.73 - 22.40
52wk Range
19.34 - 39.20
Shares Outstanding
44,454,792
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PCRX Stock Earnings: Pacira BioSciences Beats EPS, Beats Revenue for Q2 2024
July 30, 2024
PCRX stock results show that Pacira BioSciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Pacira BioSciences Reports Second Quarter 2024 Financial Results
July 30, 2024
From
Pacira BioSciences
Via
GlobeNewswire
Performance
YTD
-30.22%
-30.22%
1 Month
+8.40%
+8.40%
3 Month
-24.69%
-24.69%
6 Month
-21.62%
-21.62%
1 Year
-41.51%
-41.51%
More News
Read More
3 Biotech Stocks to Buy on the Dip: July 2024
July 29, 2024
Via
InvestorPlace
Expert Ratings For Pacira BioSciences
July 25, 2024
Via
Benzinga
Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024
July 23, 2024
From
Pacira BioSciences
Via
GlobeNewswire
NASDAQ:PCRX: good value for what you're paying.
June 26, 2024
Via
Chartmill
NASDAQ:PCRX, an undervalued stock with good fundamentals.
June 05, 2024
Via
Chartmill
Analyst Ratings For Pacira BioSciences
May 08, 2024
Via
Benzinga
In a market where value is scarce, NASDAQ:PCRX offers a refreshing opportunity with its solid fundamentals.
July 17, 2024
Via
Chartmill
Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025
July 10, 2024
From
Pacira BioSciences
Via
GlobeNewswire
Top 5 Health Care Stocks That May Explode In July
July 08, 2024
Via
Benzinga
This Charter Communications Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
July 03, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Pacira BioSciences Through Analyst Insights
July 02, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Pacira BioSciences Through 6 Analysts
April 09, 2024
Via
Benzinga
Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
May 30, 2024
From
Pacira BioSciences
Via
GlobeNewswire
When you look at NASDAQ:PCRX, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
May 15, 2024
Via
Chartmill
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
May 10, 2024
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes
May 08, 2024
From
Pacira BioSciences
Via
GlobeNewswire
PCRX Stock Earnings: Pacira BioSciences Meets EPS, Beats Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program
May 07, 2024
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
May 07, 2024
From
Pacira BioSciences
Via
GlobeNewswire
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024
April 30, 2024
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Pacira BioSciences
Via
GlobeNewswire
Despite its impressive fundamentals, NASDAQ:PCRX remains undervalued.
March 28, 2024
Via
Chartmill
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)
March 20, 2024
Via
AB Newswire
Topics
Death
Exposures
Death
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.